Biology Reference
In-Depth Information
46. Hong CS, Goins WF, Goss JR, Burton EA,
Glorioso JC (2006) Herpes simplex virus
RNAi and neprilysin gene transfer vectors
reduce accumulation of Alzheimer's disease-
related amyloid-beta peptide in vivo. Gene
Ther 13:1068-1079
47. Miki Y, Nonoguchi N, Ikeda N, Coffi n RS,
Kuroiwa T, Miyatake S (2007) Vascular endo-
thelial growth factor gene-transferred bone
marrow stromal cells engineered with a her-
pes simplex virus type 1 vector can improve
neurological defi cits and reduce infarction
volume in rat brain ischemia. Neurosurgery
61:586-594, discussion 594-85
48. Ruffi ni F, Furlan R, Poliani PL, Brambilla E,
Marconi PC, Bergami A, Desina G, Glorioso
JC, Comi G, Martino G (2001) Fibroblast
growth factor-II gene therapy reverts the clin-
ical course and the pathological signs of
chronic experimental autoimmune encepha-
lomyelitis in C57BL/6 mice. Gene Ther
8:1207-1213
49. Hsu YC, Lee DC, Chiu IM (2007) Neural
stem cells, neural progenitors, and neuro-
trophic factors. Cell Transplant 16:133-150
50. Marconi P, Zucchini S, Berto E, Bozac A,
Paradiso B, Bregola G, Grassi C, Volpi I,
Argnani R, Marzola A et al (2005) Effects of
defective herpes simplex vectors expressing
neurotrophic factors on the proliferation and
differentiation of nervous cells in vivo. Gene
Ther 12:559-569
51. Cao H, Zhang GR, Wang X, Kong L, Geller
AI (2008) Enhanced nigrostriatal neuron-
specifi c, long-term expression by using
neural-specifi c promoters in combination
with targeted gene transfer by modifi ed helper
virus-free HSV-1 vector particles. BMC
Neurosci 9:37
52. Kann O, Kovacs R, Njunting M, Behrens CJ,
Otahal J, Lehmann TN, Gabriel S, Heinemann
U (2005) Metabolic dysfunction during neu-
ronal activation in the ex vivo hippocampus
from chronic epileptic rats and humans. Brain
128:2396-2407
53. Tetz LM, Rezk PE, Ratcliffe RH, Gordon
RK, Steele KE, Nambiar MP (2006)
Development of a rat pilocarpine model of
seizure/status epilepticus that mimics chemi-
cal warfare nerve agent exposure. Toxicol Ind
Health 22:255-266
54. Lehmann TN, Gabriel S, Kovacs R, Eilers A,
Kivi A, Schulze K, Lanksch WR, Meencke HJ,
Heinemann U (2000) Alterations of neuronal
connectivity in area CA1 of hippocampal
slices from temporal lobe epilepsy patients
and from pilocarpine-treated epileptic rats.
Epilepsia 41(Suppl 6):S190-S194
55. Compston A (2006) The basis for treatment
in multiple sclerosis. Acta Neurol Scand Suppl
183:41-47
56. Fernandez O (2007) Combination therapy in
multiple sclerosis. J Neurol Sci 259:95-103
57. Furlan R, Brambilla E, Ruffi ni F, Poliani PL,
Bergami A, Marconi PC, Franciotta DM,
Penna G, Comi G, Adorini L et al (2001)
Intrathecal delivery of IFN-gamma protects
C57BL/6 mice from chronic-progressive
experimental autoimmune encephalomyelitis
by increasing apoptosis of central nervous
system-infi ltrating lymphocytes. J Immunol
167:1821-1829
58. Martino G, Poliani PL, Marconi PC, Comi G,
Furlan R (2000) Cytokine gene therapy of
autoimmune demyelination revisited using
herpes simplex virus type-1-derived vectors.
Gene Ther 7:1087-1093
59. Anesti AM, Peeters PJ, Royaux I, Coffi n RS
(2008) Effi cient delivery of RNA Interference
to peripheral neurons in vivo using herpes
simplex virus. Nucleic Acids Res 36:e86
60. Goins WF, Goss JR, Chancellor MB, de Groat
WC, Glorioso JC, Yoshimura N (2009)
Herpes simplex virus vector-mediated gene
delivery for the treatment of lower urinary
tract pain. Gene Ther 16:558-569
61. Zhou Z, Peng X, Hao S, Fink DJ, Mata M
(2008) HSV-mediated transfer of interleukin-
10 reduces infl ammatory pain through modula-
tion of membrane tumor necrosis factor alpha in
spinal cord microglia. Gene Ther 15:183-190
62. Hao S, Mata M, Glorioso JC, Fink DJ (2007)
Gene transfer to interfere with TNFalpha sig-
naling in neuropathic pain. Gene Ther
14:1010-1016
63. Mata M, Hao S, Fink DJ (2008) Gene ther-
apy directed at the neuroimmune component
of chronic pain with particular attention to
the role of TNF alpha. Neurosci Lett
437:209-213
64. Goss JR, Gold MS, Glorioso JC (2009) HSV
vector-mediated modifi cation of primary
nociceptor afferents: an approach to inhibit
chronic pain. Gene Ther 16:493-501
65. Lee JY, Fink DJ, Mata M (2006) Vector-
mediated gene transfer to express inhibitory
neurotransmitters in dorsal root ganglion
reduces pain in a rodent model of lumbar
radiculopathy. Spine (Phila Pa 1976)
31:1555-1558
66. Liu J, Wolfe D, Hao S, Huang S, Glorioso JC,
Mata M, Fink DJ (2004) Peripherally deliv-
ered glutamic acid decarboxylase gene ther-
apy for spinal cord injury pain. Mol Ther
10:57-66
Search WWH ::
Custom Search